Announcement
Inceptor Bio and GRIT Bio Cooperate to Advance IB-T101, a Next-Generation Solid Tumor CAR-T Utilizing the OUTLAST™ Platform
Inceptor Bio
PR-12-24-NI-142Dec 18, 2024
Immuno-Oncology
Building Multiple Platforms to Address Difficult-to-Treat Cancers
Derek Hennecke
Inceptor Bio
PAO-05-22-R250-09May 24, 2022
Cell and Gene Therapy
Realizing the Promise of Cell and Gene Therapy with an Advanced Manufacturing Platform
Shailesh Maingi; Mike Nicholson, Ph.D.
Inceptor Bio
PAO-01-22-R250-15Jan 31, 2022
2021 Roundup: The Year of Cell and Gene Therapy
David Alvaro, Ph.D.
Pharma's Almanac
PA734Dec 20, 2021
Cell and Gene Therapy
A Novel Approach to Drive Disruptive Innovation in Cell and Gene Therapy
Mike Nicholson, Ph.D.
Inceptor Bio
PAO-10-21-CL-14Oct 22, 2021
Cancer Research
Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers
Inceptor Bio
PR-M06-21-018Jun 14, 2021
The Future of Healthcare
How Does Inceptor Bio Envision the Future of the Pharma/Biopharma Industry?
Inceptor Bio
PAP-Q4-20-RT2-002Dec 09, 2020